| abstract |
The present application relates to mutant proteins of the fusion (F protein) of virus Parainfluenza (PIV) that are currently listed under PIV Type 5 (PIV-5 or PIV5) and PIV type 2 (PIV-2 or PIV2). The This application relates to products derived therefrom, such as: -acids nucleic, vectors, cells; fusion inhibitors antibody type, aptamers, interfering RNA; myelomas, hybridomas; cell strains and progenitors. This application is related to these mutant proteins and derived from them for their use in medical applications and biotechnology. |